RESOLUTION ON THE RESULTS OF THE FIRST WORKING MEETING OF THE SCIENTIFIC ADVISORY BOARD "ACTUAL PROBLEMS OF GLYCEMIC VARIABILITY AS A NEW CRITERION OF GLYCEMIC CONTROL AND SAFETY OF DIABETES THERAPY"

被引:3
|
作者
Antsiferov, Mikhail B. [1 ]
Galstyan, Gagik R. [2 ]
Zilov, Alexey, V [3 ]
Mayorov, Alexander Y. [2 ]
Markova, Tatyana N. [4 ,6 ]
Demidov, Nikolay A. [5 ]
Koteshkova, Olga M. [1 ]
Laptev, Dmitry N. [2 ]
Vitebskaya, Alisa V. [3 ]
机构
[1] Endocrinol Dispanserium, Moscow Hlth Care Dept, Moscow, Russia
[2] Endocrinol Res Ctr, Moscow, Russia
[3] Sechenov Univ, IM Sechenov Moscow State Med Univ 1, Moscow, Russia
[4] City Clin Hosp 52, Moscow, Russia
[5] Moskovskiy City Hosp, Moscow Hlth Dept, Moscow, Russia
[6] AI Yevdokinnov Moscow State Univ Med & Dent, Moscow, Russia
来源
DIABETES MELLITUS | 2019年 / 22卷 / 03期
关键词
variability of glycemia; fasting plasma glucose; postprandial glycemia; HbA1c; coefficient of variability; continuous glucose monitoring (CGM); self-measured blood glucose; diabetes mellitus; insulin degludec; DAY-TO-DAY; GLUCOSE VARIABILITY; OXIDATIVE STRESS; INSULIN DEGLUDEC; COMPLICATIONS; HYPOGLYCEMIA; GLARGINE; FLUCTUATIONS; ACTIVATION; MORTALITY;
D O I
10.14341/DM10227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of improving the results of diabetes mellitus (DM) treatment by considering glycaemic variability (GV) as an additional criterion for effective glycaemic control (especially in patients receiving insulin therapy) and as one of the goals of treatment in patients with unstable glycaemia. The purpose of the working meeting was to develop a strategy for the introduction of GV as a predictor and as an additional criterion for assessing the effectiveness and safety of hypoglycaemic therapy to improve the pharmacotherapy of diabetes and reduce cardiovascular and total mortality. The aims of the working meeting were to conduct a comprehensive data analysis of the relationship between GV and hypoglycaemia; to gather and analyse published data and the experience of decrease in GV and improved outcomes of diabetes against the background of different types of insulin therapy; to compare existing methods of glycaemia monitoring and GV assessment and examine their validity and availability in real practice in the context of limited budget and to analyse the informativeness and clinical and prognostic significance of various parameters of GV assessment and to determine their reasonable 'minimum' for a comprehensive assessment of GV as a criterion for evaluating the effectiveness of DM treatment and the predictors of negative diabetes outcomes. The following reports were presented during the discussion: 'Glycemic variability: clinical and prognostic value. Types of glycemic variability' (Candidate of Medical Sciences, assistant Professor Zilov A.V.); 'Methods of assessment of variability of glycemia in clinical trials and routine practice' (PhD, Professor Markova T. N.); 'Current international and national recommendations on glycemic monitoring' (PhD, Professor Galstyan G. R.) and 'Peculiarities of glycemic variability and its evaluation among children and adolescents' (Candidate of Medical Sciences Vitebskaya A.V.).
引用
收藏
页码:281 / 288
页数:8
相关论文
共 4 条
  • [1] THE SCIENTIFIC ADVISORY BOARD RESOLUTION: IMPLEMENTATION OF INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN CLINICAL PRACTICE TO IMPROVE GLYCEMIC CONTROL
    Peterkova, Valentina A.
    Ametov, Alexander S.
    Mayorov, Aleksander Y.
    Galstyan, Gagik R.
    Laptev, Dmitry N.
    Chernikova, Natalya A.
    DIABETES MELLITUS, 2021, 24 (02): : 185 - 192
  • [2] CANAGLIFLOZIN: FROM GLYCEMIC CONTROL TO IMPROVEMENT OF CARDIOVASCULAR AND RENAL PROGNOSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. RESOLUTION OF ADVISORY BOARD
    Shestakova, Marina, V
    Ametov, Alexander S.
    Antsiferov, Mikhail B.
    Bardymova, Tatyana P.
    Valeeva, Farida V.
    Galstyan, Gagik R.
    Demidova, Tatyana Yu
    Karpova, Irina A.
    Kiseleva, Tatyana P.
    Mayorov, Alexander Yu
    Mkrtumyan, Ashot M.
    Nedogoda, Sergey, V
    Petunina, Nina A.
    Ruyatkina, Ludmila A.
    Suplotova, Lyudmila A.
    Sukhareva, Olga Yu
    Fadeev, Valentin V.
    Shannkhalova, Minara S.
    DIABETES MELLITUS, 2021, 24 (05): : 479 - 486
  • [3] Use of an Automated Bolus Advisor Reduces Glycemic Variability in Poorly Controlled Diabetes Patients Treated With Multiple Daily Insulin Injection (MDI) Therapy: Results from the Automated Bolus Advisor Control and Usability Study (ABACUS)
    Ziegler, Ralph
    Cavan, David A.
    Cranston, Iain
    Barnard, Katharine
    Parkin, Christopher G.
    Koehler, Walter
    Petersen, Bettina
    Schweitzer, Matthias A.
    Wagner, Robin S.
    DIABETES, 2013, 62 : A221 - A221
  • [4] Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: results from a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 in routine clinical practice
    Shestakova, M. V.
    Akil, Ballan
    DIABETES MELLITUS, 2010, 13 (01): : 92 - 100